semaglutide generic for ozempic coming to Canada: what the patent expiry means people with diabetes – Endor Health Indian Pharma Billionaires Pile Into

As adoption of GLP-1s continues to become more and more mainstream, this trend will only intensify

#HealthNews #PharmaNews #GSK #LiverDisease #Biotech #MedicalInnovation #NextClickNews To view or add a comment, sign in -1 : GLP-1 receptor agonists are redefining how we manage type 2 diabetes and obesity and these companies are leading the way: Novo Nordisk Ozempic, Wegovy, Rybelsus Eli Lilly Mounjaro, Trulicity AstraZeneca, Sanofi Also making significant contributions with drugs like Bydureon, Adlyxin, and Soliqua With GLP-1 therapies gaining global traction due to their metabolic and cardiovascular benefits, the competition is fierce and innovation is rapid

while the base of this treatment is vitamin B12, the other ingredients include fat-busting and metabolism-increasing amino acids that work with the body to eliminate unwanted fat and remove toxins clogging up your metabolic rate

We dig deep into what you eat, how you move and sleep, how stress factors in, and and whether behavioral health would be helpful, too